Jemila Houacine is a distinguished academic leader based in Geneva, currently serving as the Chief Operating Officer at Alderaan Biotechnology and Yukin Therapeutics. With a strong background in life sciences and biotechnology, she has a proven track record of driving innovation and operational excellence in the industry. Jemila is known for her strategic vision and ability to foster collaboration among diverse teams to achieve ambitious goals. Her leadership is instrumental in advancing cutting-edge research and development initiatives within the organizations she oversees.